Current Pharmaceutical Design logo Bentham Science Publishers logo

Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

Related content
Volume 9, Number 26, October 2003

< previous issue | all issues | next issue >

Review article

CB 1954: From the Walker Tumor to NQO2 and VDEPT
pp. 2091-2104(14)
Authors: Knox, Richard J.; Burke, Philip J.; Chen, Shiuan; Kerr, David J.

Radiogenetic Therapy: Strategies to Overcome Tumor Resistance
pp. 2105-2112(8)
Authors: Marples, B.; Greco, O.; Joiner, M. C.; Scott, S. D.

Prodrugs in Genetic Chemoradiotherapy
pp. 2131-2154(24)
Authors: Patterson, Adam V.; Saunders, Mark P.; Greco, Olga

Enzyme and Proton-Activated Prodrugs for a Selective Cancer Therapy
pp. 2155-2175(21)
Authors: Tietze, L. F.; Feuerstein, T.

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page